Your browser doesn't support javascript.
loading
Pathological features of COVID-19-associated liver injury-a preliminary proteomics report based on clinical samples.
Leng, Ling; Cao, Ruiyuan; Ma, Jie; Lv, Luye; Li, Wei; Zhu, Yunping; Wu, Zhihong; Wang, Manli; Zhou, Yiwu; Zhong, Wu.
Afiliação
  • Leng L; Stem Cell and Regenerative Medicine Lab, Translational Medicine Center, Department of Medical Science Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Cao R; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
  • Ma J; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Life Omics, Beijing, 102206, China.
  • Lv L; Institute of NBC Defense, Beijing, 102205, China.
  • Li W; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
  • Zhu Y; State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Life Omics, Beijing, 102206, China. zhuyunping@gmail.com.
  • Wu Z; Stem Cell and Regenerative Medicine Lab, Translational Medicine Center, Department of Medical Science Research Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China. orthoscience@126.com.
  • Wang M; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China. wangml@wh.iov.cn.
  • Zhou Y; Department of Forensic Medicine, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, China. zhouyiwu@outlook.com.
  • Zhong W; National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. zhongwu@bmi.ac.cn.
Signal Transduct Target Ther ; 6(1): 9, 2021 01 08.
Article em En | MEDLINE | ID: mdl-33419962

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China